FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology, and represents an ophthalmic film. Film contains 0.12 g of methyluracil as a biologically active substance, and as film-forming base - 3.3 g of polyvinyl alcohol per 100.0 ml of water.
EFFECT: use of the invention provides higher corneal regeneration.
1 cl, 2 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC DRUG FILM WITH 6-METHYL-3-(THIETAN-3-YL)URACIL, HAVING WOUND-HEALING EFFECT | 2020 |
|
RU2740923C1 |
SUSPENDED METHYLURACIL FORMULATION | 1992 |
|
RU2007998C1 |
EYE FILM | 1997 |
|
RU2173178C2 |
OCULAR OINTMENT | 1994 |
|
RU2082434C1 |
EYE OINTMENT BASED ON 6-METHYL-3-(THIETAN-3-YL)URACIL WITH WOUND-HEALING EFFECT | 2019 |
|
RU2705392C1 |
EYE MEDICINAL FILM | 2009 |
|
RU2404779C1 |
METHOD OF CONSERVATIVE TREATMENT OF ADAPTED PENETRATING WOUNDS OF THE CORNEA | 2016 |
|
RU2644701C1 |
OPHTHALMOLOGIC GEL AND METHOD OF ITS PREPARATION | 2007 |
|
RU2340327C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
METHOD FOR TREATING CHRONIC CORNEAL EROSIONS | 2021 |
|
RU2776218C1 |
Authors
Dates
2021-01-21—Published
2020-06-09—Filed